Humana Stock Earnings Estimates Decreased by Zacks Research

Humana Inc. (NYSE:HUM) – Equities research analysts at Zacks Research decreased their Q3 2028 earnings estimates for shares of Humana in a research note issued on Tuesday, September 29th. Zacks Research analyst Team now forecasts that the insurance provider will post earnings of $6.58 per share for the quarter, down from their previous estimate of $6.73. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Humana’s current full-year earnings is $9.01 per share.

A number of other analysts have also recently commented on the company. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 14th. Piper Sandler raised shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 price target for the company in a research report on Thursday, July 30th. Raymond James Financial lowered Humana from an “outperform” rating to a “market perform” rating in a research note on Thursday, July 30th. Barclays raised Humana from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $407.00 to $515.00 in a report on Friday, September 25th. Finally, Cantor Fitzgerald restated a “neutral” rating on shares of Humana in a research note on Friday, September 4th. Fifteen research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $408.61.

Humana Price Performance

NYSE HUM opened at $388.40 on Friday. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The stock’s fifty day moving average price is $385.39 and its 200 day moving average price is $325.32. Humana has a 1 year low of $163.11 and a 1 year high of $428.88. The company has a market cap of $46.64 billion, a price-to-earnings ratio of 36.75, a PEG ratio of 2.40 and a beta of 0.74.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter last year, the company posted $6.27 earnings per share. The business’s quarterly revenue was up 26.2% on a year-over-year basis.

Institutional Investors Weigh In On Humana

Institutional investors have recently modified their holdings of the business. BlackRock Inc. acquired a new position in Humana in the 2nd quarter worth about $4,138,160,000. Capital International Investors increased its position in shares of Humana by 113.9% in the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after buying an additional 3,097,571 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after buying an additional 1,398,774 shares during the period. Bank of New York Mellon Corp raised its stake in shares of Humana by 21.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,094,570 shares of the insurance provider’s stock worth $536,482,000 after buying an additional 376,803 shares during the period. Finally, Franklin Resources Inc. lifted its position in shares of Humana by 914.5% during the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock valued at $321,613,000 after buying an additional 1,131,893 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.8850 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. Humana’s dividend payout ratio is 33.49%.

Humana News Summary

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate to $9.05 from $9.00 and its FY2027 forecast to $11.23 from $10.98. The firm also slightly improved its Q3 2026 and Q4 2027 estimates, suggesting some confidence in Humana’s earnings recovery. Zacks Research earnings estimates
• Positive Sentiment: Humana is expanding Medicare Advantage choices and specialized-care options for 2027 while emphasizing affordability. The offerings could support member retention and enrollment during the annual open-enrollment period. Humana 2027 Medicare Advantage plans
• Neutral Sentiment: Humana is scheduled to report third-quarter results on November 6, during Medicare Advantage open enrollment. Investors may focus on medical costs, membership trends and the financial impact of plan changes. Humana third-quarter earnings date
• Negative Sentiment: Zacks Research reduced its Q3 2028 EPS estimate to $6.58 from $6.73 and its FY2028 estimate to $29.45 from $30.30. The cuts temper the longer-term outlook, although the changes are relatively small. Humana long-term earnings estimates
• Negative Sentiment: Forecasts still call for significant seasonal losses in Q3 and Q4 2026, including estimated EPS of negative $1.13 and negative $7.75, respectively. This highlights ongoing earnings volatility and healthcare-cost risks. Humana earnings estimate report

About Humana

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.